Enhanced Biological Functions of Human Mesenchymal Stem‐Cell Aggregates Incorporating E‐Cadherin‐Modified PLGA Microparticles

Yan Zhang,Hongli Mao,Chao Gao,Suhua Li,Qizhi Shuai,Jianbin Xu,Ke Xu,Lei Cao,Ren Lang,Zhongwei Gu,Toshihiro Akaike,Jun Yang
DOI: https://doi.org/10.1002/adhm.201600114
IF: 10
2016-01-01
Advanced Healthcare Materials
Abstract:Mesenchymal stem cells (MSCs) have emerged as a promising source of multipotent cells for various cell‐based therapies due to their unique properties, and formation of 3D MSC aggregates has been explored as a potential strategy to enhance therapeutic efficacy. In this study, poly(lactic‐co‐glycolic acid) (PLGA) microparticles modified with human E‐cadherin fusion protein (hE‐cad‐PLGA microparticles) have been fabricated and integrated with human MSCs to form 3D cell aggregates. The results show that, compared with the plain PLGA, the hE‐cad‐PLGA microparticles distribute within the aggregates more evenly and further result in a more significant improvement of cellular proliferation and secretion of a series of bioactive factors due to the synergistic effects from the bioactive E‐cadherin fragments and the PLGA microparticles. Meanwhile, the hE‐cad‐PLGA microparticles incorporated in the aggregates upregulate the phosphorylation of epidermal growth factor receptors and activate the AKT and ERK1/2 signaling pathways in the MSCs. Additionally, the E‐cadherin/β‐catenin cellular membrane complex in the MSCs is markedly stimulated by the hE‐cad‐PLGA microparticles. Therefore, engineering 3D cell aggregates with hE‐cad‐PLGA microparticles can be a promising method for ex vivo multipotent stem‐cell expansion with enhanced biological functions and may offer a novel route to expand multipotent stem‐cell‐based clinical applications.
What problem does this paper attempt to address?